Weibo (WB) Reaches $134.81 After 4.00% Down Move; 5 Analysts Are Bullish MEDNAX, Inc. (MD) Last Week

February 22, 2018 - By Vivian Park

The stock of Weibo Corporation (NASDAQ:WB) is a huge mover today! The stock decreased 1.42% or $1.9447 during the last trading session, reaching $134.8053. About 693,983 shares traded. Weibo Corporation (NASDAQ:WB) has risen 239.00% since February 22, 2017 and is uptrending. It has outperformed by 222.30% the S&P500.The move comes after 6 months negative chart setup for the $29.82B company. It was reported on Feb, 22 by Barchart.com. We have $129.41 PT which if reached, will make NASDAQ:WB worth $1.19B less.

Among 18 analysts covering MEDNAX (NYSE:MD), 5 have Buy rating, 1 Sell and 12 Hold. Therefore 28% are positive. MEDNAX had 50 analyst reports since July 31, 2015 according to SRatingsIntel. The stock of MEDNAX, Inc. (NYSE:MD) has “Hold” rating given on Tuesday, December 13 by Jefferies. Mizuho downgraded MEDNAX, Inc. (NYSE:MD) on Wednesday, November 9 to “Neutral” rating. Mizuho maintained MEDNAX, Inc. (NYSE:MD) rating on Friday, October 28. Mizuho has “Buy” rating and $69 target. Stifel Nicolaus maintained the stock with “Buy” rating in Tuesday, March 8 report. The stock of MEDNAX, Inc. (NYSE:MD) has “Hold” rating given on Friday, September 1 by Robert W. Baird. The company was downgraded on Tuesday, August 25 by Zacks. The firm has “Buy” rating given on Friday, August 26 by Jefferies. The rating was downgraded by Bank of America on Friday, May 5 to “Underperform”. Citigroup maintained MEDNAX, Inc. (NYSE:MD) on Wednesday, August 17 with “Neutral” rating. On Monday, March 7 the stock rating was downgraded by Susquehanna to “Neutral”. See MEDNAX, Inc. (NYSE:MD) latest ratings:

12/02/2018 Broker: BMO Capital Markets Old Rating: Market Perform New Rating: Market Perform Old Target: $46 New Target: $58 Maintain
12/02/2018 Broker: JP Morgan Old Rating: Neutral New Rating: Neutral Old Target: $46 New Target: $55 Maintain
09/02/2018 Broker: Mizuho Rating: Hold New Target: $53.0 Maintain
08/02/2018 Broker: Piper Jaffray Rating: Buy New Target: $61.0 Maintain
08/02/2018 Broker: Stephens Rating: Buy New Target: $62.0 Maintain
08/02/2018 Broker: SunTrust Rating: Hold New Target: $58.0 Maintain
08/02/2018 Broker: Robert W. Baird Rating: Hold New Target: $54.0 Maintain
24/01/2018 Broker: Mizuho Rating: Hold New Target: $49.0 Maintain
20/12/2017 Broker: SunTrust Rating: Hold New Target: $55.0 Maintain
13/12/2017 Broker: PiperJaffray Rating: Overweight New Target: $58 Initiates Coverage On

Investors sentiment decreased to 1.55 in Q3 2017. Its down 1.07, from 2.62 in 2017Q2. It dived, as 40 investors sold Weibo Corporation shares while 48 reduced holdings. 48 funds opened positions while 88 raised stakes. 125.34 million shares or 324.34% more from 29.54 million shares in 2017Q2 were reported. Teacher Retirement Of Texas stated it has 0.02% in Weibo Corporation (NASDAQ:WB). Great West Life Assurance Can reported 19,772 shares. Stifel Financial has invested 0% in Weibo Corporation (NASDAQ:WB). Kbc Gru Nv holds 0.1% or 111,767 shares in its portfolio. Ameriprise Financial has invested 0% in Weibo Corporation (NASDAQ:WB). The Washington-based Perkins Coie Trust has invested 0.02% in Weibo Corporation (NASDAQ:WB). Two Sigma Limited Liability Corp holds 8,598 shares or 0.08% of its portfolio. Parallax Volatility Advisers L P holds 62,627 shares. Fil Ltd holds 0.14% or 484,599 shares in its portfolio. 3,900 are owned by Korea Inv Corporation. Connor Clark Lunn Investment Mgmt Limited invested in 3,475 shares. 246,770 were reported by Dsm Capital Prtnrs Ltd Llc. 701,758 were accumulated by State Street. Canada Pension Plan Invest Board has invested 0% of its portfolio in Weibo Corporation (NASDAQ:WB). Virginia Retirement Sys Et Al invested in 0% or 2,500 shares.

Analysts await Weibo Corporation (NASDAQ:WB) to report earnings on May, 15. They expect $0.45 EPS, up 114.29% or $0.24 from last year’s $0.21 per share. WB’s profit will be $99.55M for 74.89 P/E if the $0.45 EPS becomes a reality. After $0.58 actual EPS reported by Weibo Corporation for the previous quarter, Wall Street now forecasts -22.41% negative EPS growth.

Among 12 analysts covering Weibo Corp (NASDAQ:WB), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. Weibo Corp had 23 analyst reports since August 19, 2015 according to SRatingsIntel. The stock of Weibo Corporation (NASDAQ:WB) has “Buy” rating given on Tuesday, October 3 by Jefferies. Jefferies maintained the stock with “Buy” rating in Tuesday, January 23 report. JP Morgan maintained it with “Overweight” rating and $140 target in Thursday, February 15 report. UBS initiated Weibo Corporation (NASDAQ:WB) on Tuesday, January 2 with “Buy” rating. The firm earned “Hold” rating on Friday, September 4 by Zacks. Citigroup initiated the stock with “Buy” rating in Friday, August 5 report. The firm has “Overweight” rating by Morgan Stanley given on Tuesday, April 19. Jefferies maintained the shares of WB in report on Thursday, June 22 with “Buy” rating. Barclays Capital maintained it with “Overweight” rating and $100 target in Friday, August 11 report. The rating was upgraded by Morgan Stanley on Thursday, December 17 to “Overweight”.

Weibo Corporation operates as a social media platform for people to create, distribute, and discover Chinese-language content. The company has market cap of $29.82 billion. It operates through two divisions, Advertising and Marketing Services, and Other Services. It has a 86.41 P/E ratio. The firm offers self-expression products that enable its users to express themselves on its platform; social products to promote social interaction between users on its platform; discovery products to help users discover content on its platform; and notifications to notify users on Weibo account activities through SMS or push notification on their device.

MEDNAX, Inc., together with its subsidiaries, provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the United States and Puerto Rico. The company has market cap of $5.34 billion. The firm offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care; and acute and chronic pain management services. It has a 20.41 P/E ratio. It also provides maternal-fetal care, including inpatient and office clinical care to expectant mothers and their unborn babies through maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians consisting of maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors.

The stock decreased 0.05% or $0.03 during the last trading session, reaching $57.59. About 167,329 shares traded. MEDNAX, Inc. (NYSE:MD) has declined 18.20% since February 22, 2017 and is downtrending. It has underperformed by 34.90% the S&P500.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>